IL2 and COVID-19: Virus-neutralizing antibodies, determined in live-virus neutralization assays, were detected in sera from 93% COVID-19 patients, and neutralizing titers correlated with IL-2+ T cell reactivity against spike SI and SII (Figures 1D, E).